Structure Therapeutics, Inc. (GPCR)
54.07
-0.61
(-1.12%)
USD |
NASDAQ |
Apr 08, 12:30
Structure Therapeutics Cash from Investing (TTM) : 90.03M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Eli Lilly & Co. | -10.97B |
| Viking Therapeutics, Inc. | 341.39M |
| Revolution Medicines, Inc. | 118.06M |
| Novo Nordisk A/S | -12.02B |
| Kymera Therapeutics, Inc. | -521.06M |